Ownership

Find out who our shareholders are

诺维信(Novozymes)和科汉森(Chr.Hansen)合并成立了新的生物技术公司——Novonesis。我们与客户密切合作,我们将改变当今世界所有产品的生产和消费方式。

投资者 | novonesis.com

As of December 12, 2023, Chr. Hansen had one shareholder, which held 5% or more of the share capital, and two shareholders, which held 5% or more of the voting rights.

In August 2022, an analysis of the shareholder structure showed that the United States, Denmark and the United Kingdom represent the largest regional groups of institutional investors. Around 6% of shares were held by retail investors. To meet certain obligations to deliver shares under management incentive programs, Chr. Hansen held less than 1% in treasury stock. 

(Source: Annual report 2021/22, pp. 63-64)

 

Largest shareholders

Date Institution Country SHARE CAPITAL VOTING RIGHTS
09-11-2018 Novo Holdings
Denmark 21.98% 21.98%
18-09-2023 Davidson Kempner Capital
Management LP 
USA N/A 5.17%

 

As per the latest major shareholder announcements. 

分享